Researchers used targeted next-generation sequencing and droplet digital PCR to characterize KRAS and BRAF mutations in metastatic colorectal cancer patients from Kazakhstan, where molecular epidemiological data remain limited. (Frontiers in Medicine)
Kazakhstani pilot study profiles KRAS and BRAF mutations using NGS and ddPCR
The CRC Digest